APA (7th ed.) Citation

O'Shea, L. K., Abdulkhalek, S., Allison, S., Neufeld, R. J., & Szewczuk, M. R. (2014). Therapeutic targeting of Neu1 sialidase with oseltamivir phosphate (Tamiflu) disables cancer cell survival in human pancreatic cancer with acquired chemoresistance. OncoTargets & Therapy, 7, 117. https://doi.org/10.2147/OTT.S55344

Chicago Style (17th ed.) Citation

O'Shea, Leah K., Samar Abdulkhalek, Stephanie Allison, Ronald J. Neufeld, and Myron R. Szewczuk. "Therapeutic Targeting of Neu1 Sialidase with Oseltamivir Phosphate (Tamiflu) Disables Cancer Cell Survival in Human Pancreatic Cancer with Acquired Chemoresistance." OncoTargets & Therapy 7 (2014): 117. https://doi.org/10.2147/OTT.S55344.

MLA (9th ed.) Citation

O'Shea, Leah K., et al. "Therapeutic Targeting of Neu1 Sialidase with Oseltamivir Phosphate (Tamiflu) Disables Cancer Cell Survival in Human Pancreatic Cancer with Acquired Chemoresistance." OncoTargets & Therapy, vol. 7, 2014, p. 117, https://doi.org/10.2147/OTT.S55344.